![Jin Woo Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 8 M $ al 30/06/2026
Jin Woo Kim is currently the Chief Operating Officer & Director at Prestige BioPharma Ltd. He previously worked as a Director at Prestige Biologics Co., Ltd. and as a Managing Director at Qion Pte Ltd. Mr. Kim holds an MBA from New York University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/07/2026 | 1.807.620 ( 3,01 % ) | 8 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PRESTIGE BIOPHARMA LIMITED | Director de Operaciones | - |
| Empresas | Cargo | Fin |
|---|---|---|
| PRESTIGE BIOLOGICS CO., LTD. | Director/Miembro de la Junta | - |
Qion Pte Ltd. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prestige Biologics Co., Ltd.
 Prestige Biologics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies antibody pharmaceuticals | Health Technology |
Prestige BioPharma Ltd.
 Prestige BioPharma Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biosimilars and antibody therapeutics | Health Technology |
Qion Pte Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
